212 related articles for article (PubMed ID: 21428825)
1. MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
Al-Abed Y; VanPatten S
Future Med Chem; 2011 Jan; 3(1):45-63. PubMed ID: 21428825
[TBL] [Abstract][Full Text] [Related]
2. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.
El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA
Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113
[TBL] [Abstract][Full Text] [Related]
3. A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis.
Dagia NM; Kamath DV; Bhatt P; Gupte RD; Dadarkar SS; Fonseca L; Agarwal G; Chetrapal-Kunwar A; Balachandran S; Srinivasan S; Bose J; Pari K; B-Rao C; Parkale SS; Gadekar PK; Rodge AH; Mandrekar N; Vishwakarma RA; Sharma S
Eur J Pharmacol; 2009 Apr; 607(1-3):201-12. PubMed ID: 19239912
[TBL] [Abstract][Full Text] [Related]
4. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
Cheng KF; Al-Abed Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
[TBL] [Abstract][Full Text] [Related]
5. New therapeutic target in inflammatory disease: macrophage migration inhibitory factor.
Morand EF
Intern Med J; 2005 Jul; 35(7):419-26. PubMed ID: 15958113
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor.
Baugh JA; Bucala R
Crit Care Med; 2002 Jan; 30(1 Suppl):S27-35. PubMed ID: 11782558
[TBL] [Abstract][Full Text] [Related]
7. Current developments of macrophage migration inhibitory factor (MIF) inhibitors.
Xu L; Li Y; Sun H; Zhen X; Qiao C; Tian S; Hou T
Drug Discov Today; 2013 Jun; 18(11-12):592-600. PubMed ID: 23466524
[TBL] [Abstract][Full Text] [Related]
8. Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor.
Swope M; Sun HW; Blake PR; Lolis E
EMBO J; 1998 Jul; 17(13):3534-41. PubMed ID: 9649424
[TBL] [Abstract][Full Text] [Related]
9. Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor.
Garai J; Lóránd T; Molnár V
Life Sci; 2005 Aug; 77(12):1375-80. PubMed ID: 15893774
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
Nicoletti F; Créange A; Orlikowski D; Bolgert F; Mangano K; Metz C; Di Marco R; Al Abed Y
J Neuroimmunol; 2005 Nov; 168(1-2):168-74. PubMed ID: 16171874
[TBL] [Abstract][Full Text] [Related]
11. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.
Al-Abed Y; Dabideen D; Aljabari B; Valster A; Messmer D; Ochani M; Tanovic M; Ochani K; Bacher M; Nicoletti F; Metz C; Pavlov VA; Miller EJ; Tracey KJ
J Biol Chem; 2005 Nov; 280(44):36541-4. PubMed ID: 16115897
[TBL] [Abstract][Full Text] [Related]
12. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis.
Santos LL; Morand EF
Wien Med Wochenschr; 2006 Jan; 156(1-2):11-8. PubMed ID: 16465610
[TBL] [Abstract][Full Text] [Related]
13. Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.
Cvetkovic I; Al-Abed Y; Miljkovic D; Maksimovic-Ivanic D; Roth J; Bacher M; Lan HY; Nicoletti F; Stosic-Grujicic S
Endocrinology; 2005 Jul; 146(7):2942-51. PubMed ID: 15790730
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
[TBL] [Abstract][Full Text] [Related]
15. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis.
Morand EF; Leech M; Bernhagen J
Nat Rev Drug Discov; 2006 May; 5(5):399-410. PubMed ID: 16628200
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders.
Cvetkovic I; Stosic-Grujicic S
Int Immunopharmacol; 2006 Oct; 6(10):1527-34. PubMed ID: 16919824
[TBL] [Abstract][Full Text] [Related]
17. Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.
Trivedi-Parmar V; Jorgensen WL
J Med Chem; 2018 Sep; 61(18):8104-8119. PubMed ID: 29812929
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor and its role in autoimmune diseases.
Denkinger CM; Metz C; Fingerle-Rowson G; Denkinger MD; Forsthuber T
Arch Immunol Ther Exp (Warsz); 2004; 52(6):389-400. PubMed ID: 15577740
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor as a target molecule in multiple sclerosis.
Nishihira J; Ogata A
Curr Opin Investig Drugs; 2001 Jun; 2(6):778-82. PubMed ID: 11572656
[TBL] [Abstract][Full Text] [Related]
20. MIF: a key player in cutaneous biology and wound healing.
Gilliver SC; Emmerson E; Bernhagen J; Hardman MJ
Exp Dermatol; 2011 Jan; 20(1):1-6. PubMed ID: 21158933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
